Royce & Associates’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,412
| Closed | -$37K | – | 1011 |
|
|
2021
Q4 | $37K | Buy |
+1,412
| New | +$37K | ﹤0.01% | 966 |
|
|
2015
Q1 | – | Sell |
-21,539
| Closed | -$489K | – | 1288 |
|
|
2014
Q4 | $489K | Hold |
21,539
| – | – | ﹤0.01% | 1134 |
|
|
2014
Q3 | $418K | Hold |
21,539
| – | – | ﹤0.01% | 1226 |
|
|
2014
Q2 | $782K | Sell |
21,539
-9,400
| -30% | -$341K | ﹤0.01% | 1175 |
|
|
2014
Q1 | $1.2M | Buy |
30,939
+40
| +0.1% | +$1.55K | ﹤0.01% | 1124 |
|
|
2013
Q4 | $881K | Buy |
30,899
+6,299
| +26% | +$180K | ﹤0.01% | 1184 |
|
|
2013
Q3 | $881K | Hold |
24,600
| – | – | ﹤0.01% | 1191 |
|
|
2013
Q2 | $822K | Buy |
+24,600
| New | +$822K | ﹤0.01% | 1183 |
|